These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12681200)

  • 1. [Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases].
    Vadillo Font C; Hernández-García C; Pato E; Morado IC; Salido M; Júdez E; Macarrón P; Fernández-Gutiérrez B; Abásolo L; Jover JA
    Rev Clin Esp; 2003 Apr; 203(4):178-82. PubMed ID: 12681200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
    Shobha V; Chandrashekara S; Rao V; Desai A; Jois R; Dharmanand BG; Kumar S; Kumar P; Dharmapalaiah C; Mahendranath KM; Prasad S; Daware MA; Singh Y; Karjigi U; Nagaraj S; Anupama KR
    Int J Rheum Dis; 2019 Feb; 22(2):280-287. PubMed ID: 30168281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series.
    Hernández-Cruz B; Sifuentes-Osornio J; Ponce-de-León Rosales S; Ponce-de-León Garduño A; Díaz-Jouanen E
    Clin Exp Rheumatol; 1999; 17(3):289-96. PubMed ID: 10410261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analysis of latent tuberculosis infection among patients with rheumatic diseases].
    Huang AF; Luo Y; Zhao Y; Liu Y
    Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):307-10. PubMed ID: 27030621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay.
    Matulis G; Jüni P; Villiger PM; Gadola SD
    Ann Rheum Dis; 2008 Jan; 67(1):84-90. PubMed ID: 17644549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis risk among patients with systemic diseases].
    Ben m'rad M; Gherissi D; Mouthon L; Salmon-Céron D
    Presse Med; 2009 Feb; 38(2):274-90. PubMed ID: 19128925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
    Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to antituberculous drugs, Bordeaux, 1985-1993. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Dupon M; Texier-Maugein J; Leroy V; Sentilhes A; Pellegrin JL; Morlat P; Ragnaud JM; Chêne G; Dabis F
    AIDS; 1995 Jun; 9(6):577-83. PubMed ID: 7662196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey.
    Cantini F; Lubrano E; Marchesoni A; Mathieu A; Olivieri I; Salvarani C; Scarpa R; Spadaro A
    Int J Rheum Dis; 2016 Aug; 19(8):799-805. PubMed ID: 26172207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical approach to vaccination of patients with autoimmune inflammatory rheumatic diseases in Australia.
    Wong PKK; Bagga H; Barrett C; Hanrahan P; Johnson D; Katrib A; Leder K; Marabani M; Pentony P; Riordan J; White R; Young L
    Intern Med J; 2017 May; 47(5):491-500. PubMed ID: 28101910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of tuberculosis in patients receiving anti-TNF therapy for rheumatic diseases: a systematic review.
    Sartori NS; de Andrade NPB; da Silva Chakr RM
    Clin Rheumatol; 2020 May; 39(5):1439-1447. PubMed ID: 31900748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis prophylaxis in patients with steroid treatment and systemic rheumatic diseases. A case-control study.
    Hernández-Cruz B; Ponce-de-León-Rosales S; Sifuentes-Osornio J; Ponce-de-León-Garduño A; Díaz-Jouanen E
    Clin Exp Rheumatol; 1999; 17(1):81-7. PubMed ID: 10084037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium tuberculosis bacteremia in HIV-negative patients.
    Chiu YS; Wang JT; Chang SC; Tang JL; Ku SC; Hung CC; Hsueh PR; Chen YC
    J Formos Med Assoc; 2007 May; 106(5):355-64. PubMed ID: 17561470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.
    Gómez-Reino JJ; Carmona L; Angel Descalzo M;
    Arthritis Rheum; 2007 Jun; 57(5):756-61. PubMed ID: 17530674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan.
    Yu KH; See LC; Kuo CF; Chou IJ; Chou MJ
    Arthritis Care Res (Hoboken); 2013 Feb; 65(2):244-50. PubMed ID: 22899470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.
    Aguado JM; Herrero JA; Gavaldá J; Torre-Cisneros J; Blanes M; Rufí G; Moreno A; Gurguí M; Hayek M; Lumbreras C; Cantarell C
    Transplantation; 1997 May; 63(9):1278-86. PubMed ID: 9158022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis.
    Jo KW; Hong Y; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2013 Nov; 107(11):1797-802. PubMed ID: 24029000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis infection in renal transplant recipients.
    Ergun I; Ekmekci Y; Sengul S; Kutlay S; Dede F; Canbakan B; Erbay B
    Transplant Proc; 2006 Jun; 38(5):1344-5. PubMed ID: 16797298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 10-year experience of tuberculosis in solid-organ transplant recipients.
    Ulubay G; Kupeli E; Duvenci Birben O; Seyfettin EP; Dogrul MI; Ozsancak Ugurlu A; Oner Eyuboglu F; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():214-8. PubMed ID: 25894157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden.
    Jung SM; Ju JH; Park MS; Kwok SK; Park KS; Kim HY; Yim HW; Park SH
    Int J Rheum Dis; 2015 Mar; 18(3):323-30. PubMed ID: 25557144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.